North America Medical Thawing System Market By Product Type, By Sample Type, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026

The North America Medical Thawing System Market is expected to witness market growth of 9.8% CAGR during the forecast period (2020-2026).

Thawing can be considered as a process of taking a frozen item from frozen to a temperature (generally above 00C) where there is no remaining ice viz. defrosting. Thawing is frequently considered as merely the reverse process of the freezing process. Nonetheless, thawing has an inherent issue that doesn’t accompany freezing operation. Most of these bacteria that cause poisoning of food or spoilage are detected on the surfaces of many foods.

During the process of freezing, surface temperatures are decreased rapidly and bacterial proliferation is significantly limited, with bacteria becoming completely inactive below -100C. During the thawing operation, the same surface regions are the foremost to increase in temperature and bacterial proliferation can restart. On big objects prone to lengthy unrestricted thawing processes, surface spoilage can happen before the center areas have fully thawed.

The thawing system is needed for storing and transporting pharmaceutical items & services in the biopharmaceutical business. The growing adoption of the thawing system in the biopharmaceuticals business is the significant key driver of the global medical thawing system market. In addition, rising demand for thawed cells utilized in the examination and treatment of diseases, for example, heart failure, cancer, and diabetics, blood-related diseases, and advances in technology in the thawing tools are the elements which fuel the thawing system market.

Based on Product Type, the market is segmented into Manual and Automated. Based on Sample Type, the market is segmented into Blood, Ovum, Semen, Embryo and Others. Based on End Use, the market is segmented into Based on End Use, the market is segmented into Blood Bank & Transfusion centers, Hospitals, Tissue Banks, Biotechnology & Pharma and Other End Uses. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Thermo Fisher Scientific, Inc., Cardinal Health, Inc., Helmer Scientific, Inc., Sarstedt AG & Company, Boekel Scientific, Inc., Barkey GmbH & Co. KG, BioCision LLC, Sartorius AG and CytoTherm LP.

Scope of the Study

Market Segments Covered in the Report:

By Product Type

• Manual
• Automated

By Sample Type

• Blood
• Ovum
• Semen
• Embryo
• Others

By End Use

• Blood Bank & Transfusion centers
• Hospitals
• Tissue Banks
• Biotechnology & Pharma
• Other End Uses

By Country

• US
• Canada
• Mexico
• Rest of North America

Companies Profiled

• General Electric (GE) Co. (GE Healthcare)
• Thermo Fisher Scientific, Inc.
• Cardinal Health, Inc.
• Helmer Scientific, Inc.
• Sarstedt AG & Company
• Boekel Scientific, Inc.
• Barkey GmbH & Co. KG
• BioCision LLC
• Sartorius AG
• CytoTherm LP

Unique Offerings

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free